Board meetings, strategic plans, and buyer signals from Faith Sandberg-Rodriguez’s organization
Jan 1, 2028·StrategicPlan
Board
Texas Health and Human Services Strategic Plan 2028-2032
This Hyperemesis Gravidarum Strategic Plan outlines a five-year roadmap to improve the diagnosis and treatment of Hyperemesis Gravidarum (HG) in Texas. The plan focuses on two main priorities: helping clinicians and hospitals better recognize and treat HG using evidence-based protocols, and enhancing health and social support for pregnant women and infants impacted by HG. Key activities include new education initiatives for providers, developing toolkits, analyzing barriers to early prenatal care, identifying and promoting peer support, and evaluating existing interventions to strengthen awareness, timely identification, coordinated care, and ultimately improve maternal and infant health outcomes.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Texas Health and Human Services Strategic Plan 2027-2031
This document provides an update on the Statewide Behavioral Health Strategic Plan, developed by the Statewide Behavioral Health Coordinating Council (SBHCC). The plan aims to ensure a strategic statewide approach to behavioral health services, building upon previous efforts. Key focus areas include incorporating diverse voices from across Texas, addressing systemic issues like access to care, infrastructure, and policy, and implementing strategies within state agencies' authority.
Aug 1, 2026·StrategicPlan
Board
Texas Health and Human Services Long-Range Plan 2029
This long-range plan from Texas Health and Human Services provides a comprehensive analysis of state hospitals, focusing on maximizing resources to meet current and future mental health needs. It projects future bed requirements and maintenance costs, addressing challenges such as extended lengths of stay, limited community placement options, and workforce constraints. Key strategies include investing in community-based services, eliminating discharge barriers, optimizing facility use, improving staffing, enhancing forensic system coordination, strengthening competency restoration, establishing specialty hubs, modernizing technology, and expanding programming to improve patient care and support access to high-quality mental healthcare for Texans.
Jul 24, 2026·BoardMeeting
Board
Tx Hhsc Dur Board Board Meeting
The board reviewed several prospective clinical prior authorization proposals. Key discussion topics included new or revised criteria for cytokine and CAM antagonists, hyperlipidemia agents, monoclonal antibody agents, pulmonary fibrosis agents, and treatments for Cushing's syndrome. Specifically, the board evaluated criteria for drugs such as Icotyde, Redemplo, Tryngolza, Fasenra, Nemluvio, Esbriet, Jascayd, Ofev, Isturisa, Korlym, and Signifor, considering indications, dosing, and initial or renewal approval criteria for each.
Extracted from official board minutes, strategic plans, and video transcripts.
